Literature DB >> 27101901

Comparing office and telephone follow-up after medical abortion.

Melissa J Chen1, Kacie M Rounds2, Mitchell D Creinin2, Catherine Cansino2, Melody Y Hou2.   

Abstract

OBJECTIVES: Compare proportion lost to follow-up, successful abortion, and staff effort in women who choose office or telephone-based follow-up evaluation for medical abortion at a teaching institution. STUDY
DESIGN: We performed a chart review of all medical abortions provided in the first three years of service provision. Women receiving mifepristone and misoprostol could choose office follow-up with an ultrasound evaluation one to two weeks after mifepristone or telephone follow-up with a scheduled telephone interview at one week post abortion and a second telephone call at four weeks to review the results of a home urine pregnancy test.
RESULTS: Of the 176 medical abortion patients, 105 (59.7%) chose office follow-up and 71 (40.3%) chose telephone follow-up. Office evaluation patients had higher rates of completing all required follow-up compared to telephone follow-up patients (94.3% vs 84.5%, respectively, p=.04), but proportion lost to follow-up was similar in both groups (4.8% vs 5.6%, respectively, p=1.0). Medical abortion efficacy was 94.0% and 92.5% in women who chose office and telephone follow-up, respectively. We detected two (1.2%) ongoing pregnancies, both in the office group. Staff rescheduled 15.0% of appointments in the office group. For the telephone follow-up cohort, staff made more than one phone call to 43.9% and 69.4% of women at one week and four weeks, respectively.
CONCLUSIONS: Proportion lost to follow-up is low in women who have the option of office or telephone follow-up after medical abortion. Women who choose telephone-based evaluation compared to office follow-up may require more staff effort for rescheduling of contact, but overall outcomes are similar. IMPLICATIONS: Although women who choose telephone evaluation may require more rescheduling of contact as compared to office follow-up, having alternative follow-up options may decrease the proportion of women who are lost to follow-up.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medical abortion; Mifepristone; Misoprostol; Telephone follow-up

Mesh:

Substances:

Year:  2016        PMID: 27101901     DOI: 10.1016/j.contraception.2016.04.007

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  5 in total

1.  Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol.

Authors:  Ellen R Wiebe; Mackenzie Campbell; Harani Ramasamy; Michaela Kelly
Journal:  Contracept X       Date:  2020-04-11

2.  Telemedicine for medical abortion: a systematic review.

Authors:  M Endler; A Lavelanet; A Cleeve; B Ganatra; R Gomperts; K Gemzell-Danielsson
Journal:  BJOG       Date:  2019-04-25       Impact factor: 6.531

3.  Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.

Authors:  Elizabeth G Raymond; Daniel Grossman; Alice Mark; Ushma D Upadhyay; Gillian Dean; Mitchell D Creinin; Leah Coplon; Jamila Perritt; Jessica M Atrio; DeShawn Taylor; Marji Gold
Journal:  Contraception       Date:  2020-04-16       Impact factor: 3.375

4.  Self-testing for pregnancy: a systematic review and meta-analysis.

Authors:  Caitlin E Kennedy; Ping Teresa Yeh; Karima Gholbzouri; Manjulaa Narasimhan
Journal:  BMJ Open       Date:  2022-02-28       Impact factor: 2.692

Review 5.  Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.

Authors:  Megan A Cohen; Anna M Powell; Jenell S Coleman; Jean M Keller; Alison Livingston; Jean R Anderson
Journal:  Am J Obstet Gynecol       Date:  2020-06-06       Impact factor: 8.661

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.